The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Issue 9 (16th July 2021) - Shen, Yue; Eades, William; Yan, Bingfang